By simultaneously eliciting potent systemic and mucosal immunity, including TRM induction and IL-22–mediated mucosal defense, this strategy offers a feasible and strategically sound approach to strengthen global pertussis control and reduce transmission. Here, IL22 is linked to pertussis.